Scientists discovered a compound in the leaves of a common shrub, the
American beautyberry, that boosts an antibiotic’s activity against
antibiotic-resistant staph bacteria. Laboratory experiments showed that
the plant compound works in combination with oxacillin to knock down the
resistance to the drug of methicillin-resistant Staphylococcus aureus, or MRSA.
The American Chemical Society’s ACS Infectious Diseases published the finding, led by scientists at Emory University and the University of Notre Dame.
The American beautyberry, or Callicarpa americana, is native to
the southern United States. Prolific in the wild, the shrub is also
popular in ornamental landscaping. It’s known for showy clusters of
bright purple berries that begin to ripen in the summer and are an
important food source for many species of birds.
“We decided to investigate the chemical properties of the American
beautyberry because it was an important medicinal plant for Native
Americans,” says Cassandra Quave, co-senior author of the study and an assistant professor in Emory University’s Center for the Study of Human Health and Emory School of Medicine’s Department of Dermatology. Quave is also a member of the Emory Antibiotic Resistance Center
and a leader in the field of medical ethnobotany, studying how
indigenous people incorporate plants in healing practices to uncover
promising candidates for new drugs.
Micah Dettweiler, a recent Emory graduate and a staff member of the
Quave lab, is first author of the study. Christian Melander, professor
of chemistry at Notre Dame, is co-senior author.
The Alabama, Choctaw, Creek, Koasati, Seminole and other Native American
tribes relied on the American beautyberry for various medicinal
purposes. Leaves and other parts of the plant were boiled for use in
sweat baths to treat malarial fevers and rheumatism. The boiled roots
were made into treatments for dizziness, stomachaches and urine
retention, while bark from the stems and roots were made into
concoctions for itchy skin.
Previous research found that extracts from the leaves of the beautyberry
deter mosquitoes and ticks. And a prior study by Quave and colleagues
found that extracts from the leaves inhibit growth of the bacterium that
causes acne. For this study, the researchers focused on testing
extracts collected from the leaves for efficacy against MRSA.
“Even a single plant tissue can contain hundreds of unique molecules,”
Quave says. “It’s a painstaking process to chemically separate them out,
then test and retest until you find one that’s effective.”
The researchers identified a compound from the leaves that slightly
According to Erik Dalton, major part of head, neck, jaw and shoulder levitra cost melissaspetsit.com pain is due to poor posture including fibromyalgia, myofascial pain syndrome, temporomandibular joint dysfunction and chronic fatigue syndromes. Look for reviews and testimonials from best price on cialis past customers. With improved reproductive organs, more healthy semen is produced. cialis generika 40mg Most of the ED sufferers were not able to acquire this medication generic viagra cheapest look at here now just because of its prices. inhibited the growth of MRSA. The compound belongs to a group of
chemicals known as clerodane diterpenoids, some of which are used by
plants to repel predators.
Since the compound only modestly inhibited MRSA, the researchers tried it in combination with beta-lactam antibiotics.
“Beta-lactam antibiotics are some of the safest and least toxic that are
currently available in the antibiotic arsenal,” Quave says.
“Unfortunately, MRSA has developed resistance to them.”
Laboratory tests showed that the beautyberry leaf compound synergizes
with the beta-lactam antibiotic oxacillin to knock down MRSA’s
resistance to the drug.
The next step is to test the combination of the beautyberry leaf extract
and oxacillin as a therapy in animal models. If those results prove
effective against MRSA infections, the researchers will synthesize the
plant compound in the lab and tweak its chemical structure to try to
further enhance its efficacy as a combination therapy with oxacillin.
“We need to keep filling the drug-discovery pipeline with innovative
solutions, including potential combination therapies, to address the
ongoing and growing problem of antibiotic resistance,” Quave says.
Each year in the U.S., at least 2.8 million people get an
antibiotic-resistant infection and more than 35,000 people die,
according to the Centers for Disease Control and Prevention.
“Even in the midst of the COVID-19, we can’t forget about the issue of
antibiotic resistance,” Quave says. She notes that many COVID-19
patients are receiving antibiotics to deal with secondary infections
brought on by their weakened conditions, raising concerns about a later
surge in antibiotic-resistant infections.
Co-authors of the study include Emory post-doctoral fellow Gina Porras;
Emory graduate students Caitlin Risener and Lewis Marquez; Tharanga
Samarakoon, collections manager of the Emory Herbarium; and Roberta
Melander from the University of Notre Dame.
The work was supported by the National Institute of Allergy and
Infectious Disease, the National Institute of General Medical Sciences,
the Jones Ecological Research Center and Emory University.
Common North American Shrub Holds Promise For Fighting Superbug (MRSA)
by
Tags: